EQL Pharma is a pharmaceutical company. Currently, the focus is on development of niche and specialised pharmaceuticals, including everything from pharma for the treatment of diabetes, enlargement of blood vessels, as well as various infections and allergies. Primarily business is found in the Nordic market. EQL Pharma was founded in 2006 and is based in Lund.

Quotes for EQL Pharma AB

Right Now

+/-
0.5
%
2,17%
Latest
23.5
High
23.5
Low
22.5
Volume
40 515
Turnover (SEK)
944 694
Value (MSEK)
683,0

Board

CEO

  • Christer Fåhraeus

Chairman Of The Board

  • Anders Månsson

Board

  • Christer Fåhraeus
  • Lars Holmqvist
  • Linda Neckmar
  • Maria Bech
  • Rajiv I. Modi

Videos

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 31,93 31,93 2020-09-18
Cadila Pharmaceuticals Ltd 30,00 30,00 2020-06-30
Ben Hayes 4,41 4,41 2020-06-30
Avanza Pension 2,86 2,86 2020-06-30
Lars Holmqvist 1,82 1,82 2020-06-30
Lars Fåhraeus 1,53 1,53 2020-06-30
Emanuel Eriksson 1,47 1,47 2020-06-30
Martin Søkjer-Petersen 1,15 1,15 2020-06-30
Ingemar Kihlström 1,09 1,09 2020-06-30
Karin Wehlin 1,02 1,02 2020-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2020-11-06 Delårsrapport 2021-Q2

  • 2021-02-18 Delårsrapport 2021-Q3

  • 2021-05-06 Bokslutskommuniké 2021